Edward Mallinckrodt, Jr. Foundation

Edward Mallinckrodt, Jr. Foundation: Two types of awards are available and two applicants are allowed per institution. The UMN internal deadline is 11/23/16.

The first award supports early stage investigators who are in the first to fourth year of a tenure-track position,engaged in basic biomedical research that has the potential to significantly advance the understanding, diagnosis or treatment of disease. Applicants should hold M.D. and/or Ph.D. degrees and have not received R01 funding. Awards are for $60,000 per year for a period of up to three years.  

The second award supports faculty members who hold M.D. and/or Ph.D. degrees, and are in their fifth to eighth year of a tenure-track position, with support to move the project forward to the point where other independent funding can be obtained.  Candidates may have an R01.  Awards are for $100,000 per year for a period of four years.

For details for both awards visit:
http://apps.research.umn.edu/c/extramural/external_coordinated_funding.cfm
http://www.emallinckrodtfoundation.org/Guidelines.html

Hearst Foundation award

Hearst Foundation award: Addresses significant issues within their major areas of interests – culture, education, health and social service – and that primarily serve large demographic and/or geographic constituencies. The amount awarded is variable. To see past funding recipients and amounts visit:

• http://www.hearstfdn.org/funding-priorities/health/past-grant-recipients/
• http://www.hearstfdn.org/funding-priorities/social-services/past-grant-recipients/
• http://www.hearstfdn.org/funding-priorities/education/past-grant-recipients/
• http://www.hearstfdn.org/funding-priorities/culture/past-grant-recipients/

The UMN has an internal deadline of 11/15/16 to review applications. One application will be chosen to be sent to the sponsor for consideration for funding. Please see the link below for details about this opportunity.  

http://apps.research.umn.edu/c/extramural/UMGuidelines.cfm?oppid=469&yearid=2016

NIH-NINDS Fellowship grants

NIH-NINDS Fellowship grants: The National Institute on Neurological Disorders and Stroke has changed its approach to supporting post-doctoral fellows. As of December 8, 2016 receipt date, NINDS is no longer participating in the NIH-wide F32 funding mechanism. Instead, applications will only be accepted from candidates who have not yet joined the postdoc lab, or are within the first 12 months after starting in the lab. The inclusion of preliminary data in F32 applications is discouraged in order to encourage earlier submissions. Applicants will neither benefit nor be penalized if preliminary data are included. NIH-NINDS F32

Statistics in the life sciences

Statistics in the life sciences: Several recent articles offer a quick overview of common pitfalls and more robust approaches for data analysis. For more information consider: 

• Ten Simple Rules for Effective Statistical Practice in PLoS Computational Biology, 2016
• The ASA’s Statement on p-Values: Context, Process, and Purpose in The American Statistician, 2016
• Blind analysis: Hide results to seek the truth in Nature, 2015
• What is the question in Science, 2015
• Common misconceptions about data analysis and statistics in Journal of Pharmacology and Experimental Therapeutics, 2014

NIH/AHRQ/NIOSH have new policies on application appendices and post-submission materials

NIH/AHRQ/NIOSH have new policies on application appendices and post-submission materials: Effective on January 25, 2017 a new appendix policy will be implemented to clarify the rules and to decrease the withdrawal of applications for noncompliance.

• Not allowed: Accepted manuscripts and non-publicly available papers (or publications of any kind) will no longer be allowed in an appendix, but news of an article accepted for publication since submission of the application will be allowed as post-submission materials. 

• Allowed items: Informed consent/assent forms and blank surveys, forms, and other data collection instruments (as appropriate). In addition, applications containing clinical trials may include the clinical trial protocol and Investigator’s Brochure from an IND application, as appropriate — unless alternate instructions are provided in the funding opportunity announcement (FOA).

• Unless a FOA requires certain information to be included in the appendix, reviewers are not required to consider the material in their review.

Multi-Site Pilot & Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34)

Multi-Site Pilot & Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34):  NIDA and NIAAA will support the development and testing of interventions, models, and/or frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and services.  For more details see(PAR-16-456).  

Agency for Healthcare Research and Quality R21 (AHRQ)

 Agency for Healthcare Research and Quality R21 (AHRQ):  Exploratory and Developmental Grant to Improve Health Care Quality through Health Information Technology (IT). This grant will fund exploratory and developmental research grants that will contribute to the evidence base of how health IT improves health care quality. For more details see PA-14-001 and a related announcement to extend the expiration date for applications to February 17, 2017, http://grants.nih.gov/grants/guide/notice-files/NOT-HS-16-020.html